EVERINSIGHT THERAPEUTICS
EverInsight Therapeutics is a biopharmaceutical company focused on the development and commercialization of innovative drugs in ophthalmology, and neurological and psychiatric disorders in Greater China and globally.
More informations about "EverInsight Therapeutics"
AffaMed Therapeutics Announces Merger with EverInsight
Oct 14, 2020 He was also head of the Development China organization, which is responsible for all clinical development in China for the global markets. ... EverInsight Therapeutics is a …See details»
AffaMed Therapeutics Announces Merger with EverInsight …
Oct 14, 2020 AffaMed Therapeutics was founded and funded by the CBC Group in 2019.About EverInsight TherapeuticsEverInsight Therapeutics is a biopharmaceutical company focused on …See details»
AffaMed Therapeutics Announces Merger with EverInsight …
Oct 14, 2020 EverInsight Therapeutics is a biopharmaceutical company focused on the development and commercialization of innovative drugs in ophthalmology, and neurological …See details»
AffaMed and EverInsight merger announced - GaBi Online
Nov 13, 2020 AffaMed Therapeutics announced a merger agreement with EverInsight Therapeutics on 10 October 2020. ... the Development China organization, Johnson and …See details»
写意发布丨AffaMed Therapeutics宣布与EverInsight Therapeutics …
Oct 14, 2020 AffaMed Therapeutics由康桥资本于2019年投资创立。 关于EverInsight Therapeutics . EverInsight Therapeutics是一家生物制药公司，致力于在大中华地区以及全球范 …See details»
EverInsight Therapeutics acquired by AffaMed Therapeutics
Oct 14, 2020 EverInsight Therapeutics EverInsight is a biopharmaceutical company focused on the development and commercialization of innovative drugs in ophthalmology. Acquiring …See details»
EverInsight Therapeutics - Crunchbase
EverInsight is a biopharmaceutical company focused on the development and commercialization of innovative drugs in ophthalmology. New. ... Experience the new Crunchbase, powered by AI …See details»
EverInsight Therapeutics Ltd. - Drug pipelines, Patents, Clinical ...
Explore EverInsight Therapeutics Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
AffaMed Therapeutics Announces Merger with EverInsight …
Oct 14, 2020 AffaMed Therapeutics (“AffaMed”), a biopharmaceutical company focused on developing and commercializing transformative therapeutics to address ophthalmologic and …See details»
EverInsight Therapeutics - PitchBook
EverInsight Therapeutics General Information Description. Operator of a biopharmaceutical company based in Hongkong, China. The company focuses on the development and …See details»
CBC Group sets up AffaMed, EverInsight merger, eyes IPO
Oct 20, 2020 AffaMed Therapeutics announced last week that it is merging with EverInsight Therapeutics, another biopharmaceutical company. Both firms were founded by CBC, formerly …See details»
EverInsight Therapeutics - Products, Competitors, Financials, …
Oct 20, 2020 EverInsight Therapeutics in-licenses ophthalmologic and central nervous system (CNS) products. On October 14th, 2020, EverInsight Therapeutics merged with AffaMed …See details»
VistaGen Therapeutics and EverInsight Therapeutics Enter Strategic ...
Jun 25, 2020 The management team of EverInsight Therapeutics has deep expertise and an extensive track record of high-quality clinical development, regulatory affairs, CMC, business …See details»
VistaGen Therapeutics and EverInsight Therapeutics Enter Strategic ...
Jun 25, 2020 EverInsight Therapeutics is currently funded by the CBC Group. About CBC Group CBC Group (formerly C-Bridge Capital) is one of the largest and most active healthcare …See details»
EverInsight Therapeutics gets Asian rights to VistaGen’s
VistaGen Therapeutics has announced that it signed a deal giving EverInsight Therapeutics development and commercialization rights to Vistagen’s PH94B aloradine nasal spray for …See details»
AffaMed Therapeutics Announces Merger with EverInsight …
Oct 14, 2020 AffaMed Therapeutics was founded and funded by the CBC Group in 2019. About EverInsight Therapeutics. EverInsight Therapeutics is a biopharmaceutical company focused …See details»
VistaGen Everest CBC C-Bridge ChinaBio
Jun 25, 2020 EverInsight Therapeutics, a China in-licensing company, acquired China/Southeast Asia rights to a novel anxiety treatment from VistaGen (NSDQ: VTGN) of South San Francisco …See details»
AffaMed Therapeutics Announces Merger with EverInsight …
Oct 14, 2020 The combined company, which will retain the AffaMed Therapeutics name and the entity, will focus on the development of therapeutics for ophthalmologic and CNS disorders in …See details»
Treating social anxiety disorder: VistaGen and EverInsight …
Jul 14, 2020 San Francisco-based VistaGen Therapeutics has signed a licensing and collaboration agreement with Shanghai-headquartered EverInsight Therapeutics. The deal …See details»
Eterna Therapeutics Changes Name to Ernexa Therapeutics to …
1 day ago CAMBRIDGE, Mass., March 25, 2025 (GLOBE NEWSWIRE) -- Eterna Therapeutics, a leader in cell therapies for the treatment of advanced cancer and autoimmune disease, …See details»